In June, 2026, the U.S. Food and Drug Administration granted 510(k) marketing clearance to Singapore-based Cuprina Pte. Ltd., also known as Cuprina Wound Care Solutions, an indirect wholly-owned subsidiary of Cuprina Holdings, for its MEDIFLY Maggots™ product. MEDIFLY Maggots™, is a biological medical device containing disinfected larvae of the blowfly Lucilia cuprina. The product is…
Read More